Medscape

Diaphragm Pacing System May Ease Breathing in ALS Patients

April 19, 2005 — Implantation of a minimally invasive diaphragm pacing system (DPS) with therapeutic electrostimulation may help maintain diaphragm function and slow or arrest the rate of respiratory ...
Science Daily

Diaphragm pacing system benefits patients with ALS

ALS patients using diaphragm pacing experienced improved quality of life, with better sleep and daytime functioning, better breathing, and less fatigue. Respiratory failure is one of the major ...
Medscape

Diaphragm Pacing System Gets FDA Nod for ALS

September 30, 2011 — The US Food and Drug Administration (FDA) has granted approval for the use of the NeuRx Diaphragm Pacing System to aid breathing in patients with amyotrophic lateral sclerosis ...
EurekAlert!

Diaphragm pacing system receives FDA approval for use with ALS patients

An electronic system that stimulates the nerve of the diaphragm muscles has received approval from the Food and Drug Administration (FDA) for use in patients with Amyotrophic Lateral Sclerosis (ALS), ...
Healio

FDA grants premarket approval to diaphragm pacing system

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...
abc27

Synapse Biomedical Wins New Approval for Diaphragm Pacing System to Free Patients from Ventilators

OBERLIN, Ohio, April 5, 2023 /PRNewswire/ -- Synapse Biomedical, Inc. announced today that the FDA has granted premarket approval (PMA) of the NeuRx ® Diaphragm Pacing System (NeuRx DPS ®) for use in ...
Crain's Cleveland Business

FDA approval helps broaden access of Synapse Biomedical's diaphragm pacing system

Oberlin-based Synapse Biomedical recently secured U.S. Food and Drug Administration premarket approval for its diaphragm pacing system for use in patients with spinal cord injuries (SCI) who rely on ...
Grand Forks Herald

FDA approves diaphragm-pacing device

The U.S. Food and Drug Administration recently announced that it approved the NeuRx DPS RA/4 Respiratory Stimulation System, an implantable electronic device that stimulates the diaphragm and allows ...
ALZFORUM

Second Trial of Diaphragm Pacing for ALS Shuts Down

A second clinical trial of a diaphragm pacer for people with ALS has shut down early, and another hangs in limbo, as doctors and patients wonder if the surgically implanted device—meant to improve ...
BioWorld

Synapse’s diaphragm pacing system nabs FDA breakthrough status

Synapse Biomedical Inc. has won breakthrough device designation from the FDA for its Transaeris system, a diaphragm pacing system (DPS) for use in weaning patients off mechanical ventilation. The ...
BioWorld

Items Tagged with 'Transaeris diaphragm pacing system'

Synapse Biomedical Inc. has won breakthrough device designation from the FDA for its Transaeris system, a diaphragm pacing system (DPS) for use in weaning patients off mechanical ventilation. The ...